14 June 1991
COMMERCIAL ITEM DESCRIPTION
PROPYLTHIOURACIL TABLETS, USP
The General Services Administration has authorized the use of this commercial item description as a replacement for Federal Specification MIL-P-37694 which is cancelled.
Shall be Propylthiouracil Tablets, USP.
Shall be in accordance with the requirements of the USP.
All ingredients shall be of a pharmaceutical grade.
Shall contain 50 mg Propylthiouracil per tablet within the applicable assay limits for the tablets. The tablets must be considered by the FDA to be therapeutically equivalent with Propylthiouracil Tablets by Lederle Laboratories at the same dosage and administration schedule.
Each tablet shall be marked/embossed with a product identification code to identify the active ingredient(s), strength, and manufacturer. The materials used in marking/embossing the dosage forma shall be acceptable to the FDA. The actual code used for the product shall be left to the discretion of the supplier.
Workmanship. The tablets shall be free from defects which detract from their appearance or impair their serviceability.
For Size 1 - Bottle (BT). One bottle containing 100 tablets, as specified, constitutes one unit.
For Size 2 - Bottle (BT). One bottle containing 1000 tablets, as specified, constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business